{"transactions":[{"id":1187061,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-01T22:42:31.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001641172-25-002185","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002185/ownership.xml","form_type":"4"}},{"id":1187060,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T22:42:31.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":55665,"source":{"system":"sec-edgar","filing":"0001641172-25-002185","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002185/ownership.xml","form_type":"4"}},{"id":1307145,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-09T00:12:29.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001911051-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105125000001/primary_doc.xml","form_type":"4"}},{"id":1307144,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-09T00:12:29.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":50665,"source":{"system":"sec-edgar","filing":"0001911051-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105125000001/primary_doc.xml","form_type":"4"}},{"id":1395397,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-02T21:19:48.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001911051-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105124000001/primary_doc.xml","form_type":"4"}},{"id":1395396,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:19:48.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":45665,"source":{"system":"sec-edgar","filing":"0001911051-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105124000001/primary_doc.xml","form_type":"4"}},{"id":1423597,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-26T11:16:12.000Z","date":"2024-08-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-100339","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024100339/ownership.xml","form_type":"4"}},{"id":1435257,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:23:41.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":15381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024."}],"balance_after":40665,"source":{"system":"sec-edgar","filing":"0000950170-24-096277","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024096277/ownership.xml","form_type":"4"}},{"id":1698186,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-29T21:09:27.000Z","date":"2023-08-28","kind":"grant","planned":false,"acquired":true,"shares":13252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. The restricted stock units vest 1/3 on each of June 1, 2023, September 1, 2023 and December 1, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This report is being filed to correct the grant date of the restricted stock units."}],"balance_after":25284,"source":{"system":"sec-edgar","filing":"0001911051-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105123000004/primary_doc.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1823034,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-26T23:34:28.000Z","date":"2023-07-25","kind":"grant","planned":false,"acquired":true,"shares":13252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. The restricted stock units vest\n1/3 on each of June 1, 2023, September 1, 2023 and December 1, 2023."}],"balance_after":25284,"source":{"system":"sec-edgar","filing":"0001911051-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105123000003/primary_doc.xml","form_type":"4"}},{"id":1823033,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-26T23:28:37.000Z","date":"2023-07-24","kind":"purchase","planned":false,"acquired":true,"shares":754,"price":3.98,"value":3000.92,"ownership":{"direct":true},"balance_after":12032,"source":{"system":"sec-edgar","filing":"0001911051-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105123000002/primary_doc.xml","form_type":"4"}},{"id":2020769,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-02-14T01:32:00.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":66254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. The restricted stock units will vest on April 1, 2023."}],"balance_after":169199,"source":{"system":"sec-edgar","filing":"0001911051-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105123000001/primary_doc.xml","form_type":"4"}},{"id":2172204,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2022-08-30T01:57:10.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a \"unit\"), at a price of $0.75 per unit."}],"balance_after":6667,"derivative":{"exercise_price":0.88,"exercise_date":"2022-08-25","expiration_date":"2027-08-25","underlying":"Common stock, par value $0.001","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001911051-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105122000003/primary_doc.xml","form_type":"4"}},{"id":2172203,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-30T01:57:10.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a \"unit\"), at a price of $0.75 per unit."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total reflects the adjustment of 3,393 shares of common stock previously reported as part of a restricted stock unit grant made on March 31, 2022."}],"balance_after":102945,"source":{"system":"sec-edgar","filing":"0001911051-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105122000003/primary_doc.xml","form_type":"4"}},{"id":2309434,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T00:29:17.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":99671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022."}],"balance_after":99671,"source":{"system":"sec-edgar","filing":"0001911051-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105122000002/primary_doc.xml","form_type":"4"}}]}